TSVT – 2seventy bio, inc. (US:NASDAQ)
Stock Stats
News
2seventy bio, Inc. (NASDAQ: TSVT) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "sell" rating. They now have a $2.00 price target on the stock, down previously from $5.00.
2seventy bio to Participate in Upcoming Investor Conferences
2seventy bio, Inc. (NASDAQ: TSVT) was upgraded by analysts at Canaccord Genuity Group Inc. to a "strong-buy" rating.
2seventy bio, Inc. (NASDAQ: TSVT) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $12.00 to $11.00. They now have a "buy" rating on the stock.
2seventy bio Reports First Quarter Financial Results and Recent Operational Progress [Yahoo! Finance]
Form 4 2seventy bio, Inc. For: Jun 10 Filed by: Wei Lin
Form 4 2seventy bio, Inc. For: Jun 10 Filed by: Maus Marcela V.
Form 4 2seventy bio, Inc. For: Jun 10 Filed by: Glickman Sarah JS
Form 4 2seventy bio, Inc. For: Jun 10 Filed by: Torres Denice
Form 4 2seventy bio, Inc. For: Jun 10 Filed by: Newton Charles W.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.